These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19765809)

  • 21. [Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].
    Yu Z; Ji M; Hu X; Yan J; Jin Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):34-38. PubMed ID: 28459401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention.
    Perri T; Korach J; Ben-Baruch G; Jakobson-Setton A; Ben-David Hogen L; Kalfon S; Beiner M; Helpman L; Rosin D
    Eur J Surg Oncol; 2014 Jul; 40(7):899-904. PubMed ID: 24268761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. POSSUM is an optimal system for predicting mortality due to colorectal perforation.
    Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K
    Hepatogastroenterology; 2008; 55(82-83):430-3. PubMed ID: 18613381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arterial pH and arterial oxygenation are not essential for risk stratification in perforation peritonitis.
    Agrawal S; Sharma D; Raina VK
    Indian J Gastroenterol; 1999; 18(1):5-6. PubMed ID: 10063737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of laparotomy for intestinal perforation in very low birth weight infants.
    Baird R; Puligandla PS; St Vil D; Dube S; Laberge JM
    J Pediatr Surg; 2006 Sep; 41(9):1522-5. PubMed ID: 16952585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the APACHE II scoring system to determine mortality of gynecologic oncology patients in the intensive care unit.
    Van Le L; Fakhry S; Walton LA; Moore DH; Fowler WC; Rutledge R
    Obstet Gynecol; 1995 Jan; 85(1):53-6. PubMed ID: 7800324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for mortality in left colonic peritonitis: a new scoring system.
    Biondo S; Ramos E; Deiros M; Ragué JM; De Oca J; Moreno P; Farran L; Jaurrieta E
    J Am Coll Surg; 2000 Dec; 191(6):635-42. PubMed ID: 11129812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of serum cholinesterase in the prognosis of septic shock].
    Zhao R; Zhang X; Wang H; Zhang R; Duan X; Liu S; Han B; Ding X; Wang D; Sun T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):44-49. PubMed ID: 32148230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity scoring systems for prognosis and efficacy of polymyxin B-immobilized fiber treatment for colonic perforation.
    Komatsu S; Shimomatsuya T; Nakajima M; Ono S; Maruhashi K
    Surg Today; 2006; 36(9):807-10. PubMed ID: 16937285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic value of red blood cell distribution width for severe acute pancreatitis.
    Zhang FX; Li ZL; Zhang ZD; Ma XC
    World J Gastroenterol; 2019 Aug; 25(32):4739-4748. PubMed ID: 31528098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute colonic perforation associated with colorectal cancer.
    Khan S; Pawlak SE; Eggenberger JC; Lee CS; Szilagy EJ; Margolin DA
    Am Surg; 2001 Mar; 67(3):261-4. PubMed ID: 11270886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful?
    Gunderson CC; Farrell R; Dinh BC; Thomas ED; Vesely SK; Lauer JK; Kao L; Chopra S; McMeekin DS; Moore KN
    Gynecol Oncol; 2013 Sep; 130(3):411-5. PubMed ID: 23791827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement.
    Diver E; O'Connor O; Garrett L; Boruta D; Goodman A; Del Carmen M; Schorge J; Mueller P; Growdon W
    Gynecol Oncol; 2013 May; 129(2):332-5. PubMed ID: 23402902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOFA score predicts postoperative outcome of patients with colorectal perforation.
    Ochiai T; Hiranuma S; Takiguchi N; Ito K; Kawaguchi A; Iwai T; Arii S
    Hepatogastroenterology; 2004; 51(58):1007-10. PubMed ID: 15239235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: a retrospective cohort study.
    Sfakianos GP; Numnum TM; Halverson CB; Panjeti D; Kendrick JE; Straughn JM
    Gynecol Oncol; 2009 Sep; 114(3):424-6. PubMed ID: 19552944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of risk indices in continuous-flow left ventricular assist device patients.
    Schaffer JM; Allen JG; Weiss ES; Patel ND; Russell SD; Shah AS; Conte JV
    Ann Thorac Surg; 2009 Dec; 88(6):1889-96. PubMed ID: 19932256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010.
    Hou JY; Aparo S; Ghalib M; Chaudhary I; Shah U; Swami U; Einstein M; Goldberg GL; Mani S; Goel S
    Gynecol Oncol; 2013 Oct; 131(1):163-8. PubMed ID: 23877015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical course and proposed treatment strategy for ERCP-related duodenal perforation: a multicenter analysis.
    Jin YJ; Jeong S; Kim JH; Hwang JC; Yoo BM; Moon JH; Park SH; Kim HG; Lee DK; Jeon YS; Lee DH
    Endoscopy; 2013 Oct; 45(10):806-12. PubMed ID: 23907814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
    Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
    World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.